About: A Proposed Plan for Prenatal Care to Minimize Risks of COVID-19 to Patients and Providers: Focus on Hypertensive Disorders of Pregnancy

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: A Proposed Plan for Prenatal Care to Minimize Risks of COVID-19 to Patients and Providers: Focus on Hypertensive Disorders of Pregnancy Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	A Proposed Plan for Prenatal Care to Minimize Risks of COVID-19 to Patients and Providers: Focus on Hypertensive Disorders of Pregnancy
Creator	Barton, John Saade, George Sibai, Baha
Source	Medline; PMC
abstract	Hypertensive disorders are the most common medical complications of pregnancy and a major cause of maternal and perinatal morbidity and death. The detection of elevated blood pressure during pregnancy is one of the cardinal aspects of optimal antenatal care. With the outbreak of novel coronavirus disease 2019 (COVID-19) and the risk for person-to-person spread of the virus, there is a desire to minimize unnecessary visits to health care facilities. Women should be classified as low risk or high risk for hypertensive disorders of pregnancy and adjustments can be accordingly made in the frequency of maternal and fetal surveillance. During this pandemic, all pregnant women should be encouraged to obtain a sphygmomanometer. Patients monitored for hypertension as an outpatient should receive written instructions on the important signs and symptoms of disease progression and provided contact information to report the development of any concern for change in status. As the clinical management of gestational hypertension and preeclampsia is the same, assessment of urinary protein is unnecessary in the management once a diagnosis of a hypertensive disorder of pregnancy is made. Pregnant women with suspected hypertensive disorders of pregnancy and signs and symptoms associated with the severe end of the disease spectrum (e.g., headaches, visual symptoms, epigastric pain, and pulmonary edema) should have an evaluation including complete blood count, serum creatinine level, and liver transaminases (aspartate aminotransferase and alanine aminotransferase). Further, if there is any evidence of disease progression or if acute severe hypertension develops, prompt hospitalization is suggested. Current guidelines from the American College of Obstetricians and Gynecologists (ACOG) and The Society for Maternal-Fetal Medicine (SMFM) for management of preeclampsia with severe features suggest delivery after 34 (0/7) weeks of gestation. With the outbreak of COVID-19, however, adjustments to this algorithm should be considered including delivery by 30 (0/7) weeks of gestation in the setting of preeclampsia with severe features. Key Points: Outbreak of novel coronavirus disease 2019 (COVID-19) warrants fewer office visits. Women should be classified for hypertension risk in pregnancy. Earlier delivery suggested with COVID-19 and hypertensive disorder.
has issue date	2020-05-12(xsd:dateTime)
bibo:doi	10.1055/s-0040-1710538
bibo:pmid	32396947
has license	no-cc
sha1sum (hex)	7431084d89e77a3fb9003dc4d019ea2321c1b863
schema:url	https://doi.org/10.1055/s-0040-1710538
resource representing a document's title	A Proposed Plan for Prenatal Care to Minimize Risks of COVID-19 to Patients and Providers: Focus on Hypertensive Disorders of Pregnancy
has PubMed Central identifier	PMC7356071
has PubMed identifier	32396947
schema:publication	Am J Perinatol
resource representing a document's body	covid:7431084d89e77a3fb9003dc4d019ea2321c1b863#body_text
is schema:about of	named entity 'ELEVATED BLOOD PRESSURE' named entity 'PROTEIN ' named entity 'PERSON' named entity 'WEEKS OF GESTATION' named entity 'HOSPITALIZATION' named entity 'SOCIETY' named entity 'IMPORTANT' named entity 'DEVELOPMENT' named entity 'SUSPECTED' named entity 'VISUAL SYMPTOMS' named entity 'REPORT' named entity 'DISEASE PROGRESSION' named entity 'LIVER' named entity 'MANAGEMENT' named entity 'liver' named entity 'gestational hypertension' named entity 'hypertension' named entity 'complications of pregnancy' named entity 'SMFM' named entity 'ACOG' named entity 'preeclampsia' named entity 'alanine aminotransferase' named entity 'outpatient' named entity 'hypertensive disorders of pregnancy' named entity 'preeclampsia' named entity 'serum creatinine' named entity 'pregnancy' named entity 'hypertension' named entity 'hypertensive disorder' named entity 'COVID-19' named entity 'Society for Maternal-Fetal Medicine' named entity 'Chronic hypertension' named entity 'pregnant women' named entity 'preeclampsia' named entity 'mm Hg' named entity 'virus' named entity 'fetal movement' named entity 'signs/symptoms' named entity 'outpatient' named entity 'postpartum' named entity 'low platelet count' named entity 'fetal' named entity 'perinatal' named entity 'preeclampsia' named entity 'liver enzymes' named entity 'arteriolar' named entity 'randomized trials' named entity 'diastolic' named entity 'intravenous' named entity 'Pregnant women' named entity 'medical intervention' named entity 'weeks of gestation' named entity 'hypertension' named entity 'Fetal testing' named entity 'loading dose' named entity 'amniotic fluid' named entity 'headache' named entity 'signs and symptoms' named entity 'cerebrovascular' named entity 'pathognomonic' named entity 'prenatal' named entity 'hypertension' named entity 'fetal weight' named entity 'antihypertensive therapy' named entity 'preeclampsia' named entity 'headache' named entity 'pregnancy' named entity 'medical record' named entity 'chronic hypertension' named entity 'pregnant women' named entity 'chronic hypertension' named entity 'fetus' named entity 'caffeinated' named entity 'prenatal care' named entity 'preeclampsia' named entity 'diabetes' named entity 'preeclampsia' named entity 'follow-up' named entity 'complete blood count'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software